1 of 26

SARS CoV 2 super-spreaders �(and super-spreading Variant of Concern 202012/01)

Marek Kochańczyk, Frederic Grabowski, Grzegorz Preibisch , Stanisław Giziński and Tomasz Lipniacki

Institute of Fundamental Technological Research,

Polish Academy of Sciences, Warsaw, Poland

Department of Mathematics, MISMAP

2 of 26

SARS CoV 2 super-spreaders

3 of 26

R0 – basic reproduction number

  • definition: Expected number of secondary cases infected by a single primary case (without any protective measures)
  • critical parameter characterizing an outbreak
  • actual value matters:

It informs about extent of control measures required to stop pandemic

It determines the immune proportion required to achieve herd immunity: 1 – 1/R0

4 of 26

Our R0 estimate based on spring, 2020

wave of pandemic

Early WHO R0 estimate, based on epidemic in China

R0 = 4.7–11.4

R0 = 1.4–2.5

5 of 26

SEIR model

~ Lauer et al. (2020) medRxiv

 

6 of 26

SEIR model (variant)

~ Lauer et al. (2020) medRxiv

 

7 of 26

8 of 26

R0(Td)

Weaver et al.

(2005) PLoS Med.

also: Kochańczyk et al.

(2020) MMNP

R0

estimation based on the doubling time Td

9 of 26

Doubling time (Td)

  • based on cases:

(2 weeks after 100 exceed)

10 of 26

Doubling time (Td)

  • based on deaths:

(2 weeks after 10 exceed)

11 of 26

this study

Kucharski et al.

(2020) Lancet

Wu et al.

(2020) Lancet

R0 = 4.7–11.4

Reproduction numer estimate based on the doubling time

12 of 26

in contrast to nearly all early estimates…

13 of 26

R0 of COVID-19, early reports from WHO

“Human-to-human transmission is occurring and a preliminary R0 estimate of 1.4–2.5 was presented.”

(January 2020)

“The dynamics likely approximated mass action and radiated from Wuhan to other parts of Hubei province and China, which explains a relatively high R0 of 2–2.5.”

(February 2020)

14 of 26

R0 of COVID-19, early reports, other

(Boldog et al., February 2020, J. Clin. Med.)

15 of 26

Underestimation of R0 was caused by� �overestimation of the doubling time (Td)

(2020) Lancet

(2020) Nat. Med.

(2020) Lancet

(2020) NEJM

τ =

16 of 26

Lack of super-spreading,

in the early chain of epidemic transmissions,

caused overestimation of the doubling time (Td)

17 of 26

SEIR model stochastic dynamics with super-spreading

SEIR model stochastic simulations:

100 trajectories, hyper-spreaders (:= responsible for ⅔ of infections) ρ = 1%

18 of 26

SEIR model stochastic simulations:

5000 trajectories per histogram

Td in the presence of super-spreading

19 of 26

Td

20 of 26

Take-home message:

If you estimate R0 at the very beginning of the outbreak,

you will likely underestimate its value.

21 of 26

End of part one�����

Published in RSOS

22 of 26

Super-spreading Variant of Concern 202012/01

23 of 26

Spread of A20.EU1 (A222V substitution) and VOC-202012/01 in England,

GISAID data

24 of 26

Variant of Concern 202012/01 mutations:

also known as B.1.1.7 lineage, first collected on September 20, 2020, in Kent, UK

(GISAID sequence accession number EPI_ISL_601443).

The lineage, characterized by nine spike protein mutations

Deletions: 69‐70HV, 145V;

Substitutions: N501Y, A570D, D614G, P681H, T716I, S982A, D1118H

25 of 26

Replicative advantage of VOC 202012/01 in England,

with respect to A20.EU1, GISAID data

RtVOC/Rt20A.EU1 = 2.17 [95% CI: 1.98–2.37]

for 43–47 week fitting window

RtVOC/Rt20A.EU1 = 1.85 [95% CI: 1.74–1.97]

For 43-51 week fitting window

RtVOC/Rt20A.EU1 in (1.85 -2.17)

Grabowski et al. Viruses 2021

26 of 26

CONCLUSONS

The VOC 202012/01 strain had about twofold replicative advantage over the A20.EU1 strain of SARS‐CoV‐2, that was dominating in England in November, 2020.

The replication numer R0 of SARS-CoV-2 is increasing due to advantageous mutations.

Comment: at some point advantageous mutations are those allowing to infected vaccinated or recovered individuals

Thank You !